Influenza Clinical Trials

A listing of Influenza medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 14 clinical trials
A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine GSK3206641A Administered in Adults 18 to 64 Years of Age and 65 Years of Age and Older

Study to evaluate the safety and immunogenicity of H7N9 antigen in combination with full or half doses of AS03 adjuvant system in healthy adults.

vaccination
tubal ligation
immunomodulators
hysterectomy
trivalent influenza vaccine
  • 0 views
  • 04 Jun, 2021
  • 1 location
Conditioning Electrical Stimulation to Improve Outcomes in Carpal Tunnel Syndrome

entering the wrist and can result in weakened grip strength and poor dexterity. Despite surgical release, nerve damage due to chronic compression often cannot be completely reversed, with resulting

grip
carpal tunnel release
conservative management
nerve conduction
nerve conduction study
  • 67 views
  • 09 May, 2021
  • 1 location
Human Mesenchymal Stem Cells (LMSCs) on Vaccine-Specific Antibody- Response in Subjects With Aging Frailty

This is a phase I/II, randomized, blinded and placebo-controlled study to test the safety and efficacy of LMCSs for improving vaccine immune response.

  • 190 views
  • 24 Jan, 2021
  • 6 locations
Phase I/IIa Trial of scAAV1.tMCK.NTF3 for Treatment of CMT1A

This clinical trial is an open-label one-time injection dose study in which scAAV1.tMCK.NTF3 will be administered by intramuscular injections into muscles in both legs in CMT1A subjects with PMP22 gene duplication. Three subjects ages 18 to 35 years receiving (8.87e11 vg/kg) will be enrolled.

  • 181 views
  • 26 Jan, 2021
  • 1 location
Immunopheresis Alone or In Combination With Chemotherapy Versus Chemotherapy Alone in Advanced Triple Negative Breast Cancer (TNBC)

This is a multicenter, open-label, Phase 1/ 2 study to evaluate the short-term and longer-term safety, tolerability, and effectiveness of immunopheresis with the LW-02 device in removal of Soluble Tumor Necrosis Factor Receptors (sTNF-Rs) from plasma of patients with advanced, refractory Triple Negative Breast Cancer (TNBC) and for disease control …

  • 30 views
  • 27 Jan, 2021
  • 6 locations
A Trial to Evaluate the Safety and Efficacy of oNKord in Subjects With Acute Myeloid Leukemia

WiNK is a Phase I/IIa trial to evaluate the safety and efficacy of oNKord in 33 adults with acute myeloid leukemia (AML) who are in morphologic complete remission with residual measurable disease and with no strong indication for hematopoietic stem cell transplantation.

cell transplantation
acute promyelocytic leukemia
fludarabine
hematologic disorder
remission
  • 0 views
  • 24 May, 2021
  • 8 locations
hCT-MSCs for COVID19 ARDS

This is a 30 patient, Phase 1/2a multi-center pilot study to test the safety and to describe the preliminary efficacy of intravenous administration of allogenic human cord tissue mesenchymal stromal cells (hCT-MSC) as an investigational agent, under U.S. IND 19968 to patients with acute respiratory distress syndrome (ARDS) due to …

covid-19
FIO2
mechanical ventilation
acute respiratory distress syndrome
pao2/fio2 ratio
  • 47 views
  • 03 Jun, 2021
  • 1 location
Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients

To measure the effect of Ivermectin (sub-cutaneous) with or without zinc in treating the COVID-19 patients to clear viral load of SARS-CoV-2 along with reduction in severity of symptoms and length of hospitalization of patients with COVID-19.

SARS
ivermectin
covid-19
zinc
  • 0 views
  • 26 Feb, 2021
  • 2 locations
Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL

from cytokine release syndrome vary from flu-like symptoms to more severe side effects such as cardiac arrest, multi-system organ failure or death. We predict that about 50% of patients on this study

lymphoblasts
renal function
bacterial infection
ponatinib
t315i mutation
  • 28 views
  • 24 Jan, 2021
  • 1 location
A Study of the Safety and Efficacy of EBV Specific T-cell Lines

This study evaluates the safety and efficacy of EBV-specific T-cell lines to treat patients suffering from high EBV viral titers not responding to standard of care therapies and to treat EBV-related lymphoma. The study will recruit 6 patients to receive autologous T cells or a T cell line derived from …

lymphoma
stem cell transplantation
  • 29 views
  • 26 Jan, 2021
  • 2 locations